Point Of Care Infectious Disease Testing Market Size Growth - By Technology, By Disease (HIV POC, Clostridium Difficile POC), By End-use, and By Region: Statistics Reports, Supply & Demand Analysis, Global Opportunity 2024-2030

Key Players: 

• Technology Outlook

  • Lateral Flow Immunoassay

  • Agglutination Test

  • Flow-through test/Immunoconcentration Assay

  • Molecular Diagnostics

  • Others

• Disease Outlook

  • HIV POC

  • Clostridium Difficile POC

  • HBV POC

  • Pneumonia Or Streptococcus Associated Infections

  • Respiratory Syncytial Virus (RSV) POC

  • HPV POC

  • Influenza/Flu POC

  • HCV POC

  • MRSA POC

  • TB & Drug-resistant TB POC

  • HSV POC

  • COVID-19

  • Other Infectious Diseases

• End Use Outlook

  • Clinics

  • Hospitals

  • Home

  • Assisted Living Healthcare Facilities

  • Laboratory

• Regional Outlook

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Key players in the industry are adopting growth strategies like partnerships, collaborations, mergers and acquisitions, and awareness programs to strengthen their market presence. The report also lists industry players for end users, facilitating communication between manufacturers and consumers.

Recent Market Updates:

• In January 2024, Roche acquired LumiraDx’s point of care technology. The LumiraDx’s platform includes a range of immunoassay and clinical chemical tests. The addition of LumiraDx’s to Roche may enable the company to transform testing at the point of care.

• In February 2023, Thermo Fisher partnered with Mylab, announced to launch made-in-India RTPCR kits for infectious disease in India. Mylab in partnership with Thermo Fisher aims to access of the test to a greater portion of the population in India as well as the world.

Regional Analysis for Point Of Care Infectious Disease Testing Market:

• North America(the United States, Canada, and Mexico)
• Europe(Germany, France, UK, Russia, and Italy)
• Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)
• South America(Brazil, Argentina, Colombia, etc.)
• The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) 

The Research Provides Answers to the Following Key Questions:

1. What is the expected growth rate of the Point Of Care Infectious Disease Testing market from 2024 to 2030?
2. What are the major driving forces shaping the industry?
3. Who are the major vendors dominating the market, and what are their winning strategies?
4. What trends can business owners expect in the coming years?
5. What threats and challenges might hinder industry progress?
6. What opportunities can business owners capitalize on from 2024 to 2030?